Cumberland Pharmaceuticals (CPIX) Acquisitions (2018 - 2025)

Cumberland Pharmaceuticals (CPIX) reported Acquisitions of $1.0 million for Q4 2025, up 68.33% sequentially from $611600.0 in Q3 2025.

Cumberland Pharmaceuticals (CPIX) Acquisitions (2018 - 2025) Analysis & Trends

Cumberland Pharmaceuticals (CPIX) has 3 years of Acquisitions data on file, last reported at $1.0 million in Q4 2025.

For the quarter ending Q4 2025, Acquisitions changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Dec 2025 stood at $2.5 million (changed N/A YoY), and the FY2025 full-year result was $2.5 million, changed N/A from the prior year.
Acquisitions grew to $1.0 million in Q4 2025, from $611600.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $13.5 million in Q1 2022 to a low of -$326262.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Cumberland Pharmaceuticals	104.57 Mn	93.23 Mn	7.20 Mn	-

Download Data